arrow
A

Amin H. Nassar

Yale University School of Medicine
H指数:27
被引数:3,325

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study

免疫疗法在伴有心包积液的晚期NSCLC中的有效性和安全性:一项全球回顾性多中心研究

2026-07-250
OAAI
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer

曲妥珠单抗德鲁克替康在晚期乳腺癌中的分子与临床疗效洞察

2025-12-040
PRE
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性

2025-10-160
OAAI
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

肺大细胞神经内分泌癌的整合分子与临床特征分析

2025-08-190
OA
Comment on Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study Response

关于在不可切除的EGFR突变非小细胞肺癌中,对比巩固治疗奥希替尼与度伐利尤单抗与观察随访的多中心回顾性队列研究:疗效应答

2025-01-010
PRE
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
2024-08-012
OA
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma

肉瘤样分化的表观基因组特征指导肾细胞癌的治疗

2024-06-010
OA
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study
2024-02-012
OA
Biomarker benchmarking across ancestral populations

跨祖先人群的生物标志物基准

2023-12-010
PRE
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
2023-11-243
OAAI
Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation of renal cell carcinoma (RCC)

表观基因组分析提名主转录因子 (TFs) 驱动肾细胞癌 (RCC) 的肉瘤样分化

2023-08-150
PRE
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
2023-08-1117
PRE
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

肾细胞癌危险位点的表观基因组图谱及功能注释

2023-01-2113
OAAI
Germline variants associated with toxicity to immune checkpoint blockade

与免疫检查点阻断毒性相关的种系变异

2022-12-1653
OA
SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS (ICI) IN PATIENTS LIVING WITH HIV (PLWH) AND METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A MATCHED COHORT STUDY FROM THE INTERNATIONAL CATCH-IT CONSORTIUM
2022-11-070
OA